MULLARKEY MATTHEW T 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Nov 17, 2009
Insider Transaction Report
Form 4
MULLARKEY MATTHEW T
Chief Operating Officer
Transactions
- Award
Common Stock
2009-11-13$38.18/sh+18.13$692→ 43.873 total(indirect: Non-Qualified Deferred Compensation Plan)
Holdings
- 377.453
Common Stock
- 90.904(indirect: By Savings Plan)
Common Stock
Footnotes (1)
- [F1]Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.